Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation

被引:42
|
作者
Gilbert, Jessica R. [1 ]
Zarate, Carlos A., Jr. [1 ]
机构
[1] NIMH, Expt Therapeut & Pathophysiol Branch, NIH, 10 Ctr Dr,MSC 1282, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
Ketamine; Electrophysiology; Gamma; Long-term potentiation; Dynamic causal modeling; NMDA RECEPTOR BLOCKADE; D-ASPARTATE ANTAGONIST; EVOKED-POTENTIALS; OSCILLATIONS; DISORDER; INTERNEURONS; MECHANISMS; FREQUENCY; EFFICACY; TRIAL;
D O I
10.1016/j.pbb.2020.172856
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Over the last two decades, the discovery of ketamine's antidepressant properties has galvanized research into the neurobiology of treatment-resistant depression. Nevertheless, the mechanism of action underlying antidepressant response to ketamine remains unclear. This study reviews electrophysiological studies of ketamine's effects in individuals with depression as well as healthy controls, with a focus on two putative markers of synaptic potentiation: gamma oscillations and long-term potentiation. The review focuses on: 1) measures of gamma oscillations and power and their relationship to both acute, psychotomimetic drug effects as well as delayed antidepressant response in mood disorders; 2) changes in long-term potentiation as a promising measure of synaptic potentiation following ketamine administration; and 3) recent efforts to model antidepressant response to ketamine using novel computational modeling techniques, in particular the application of dynamic causal modeling to electrophysiological data. The latter promises to better characterize the mechanisms underlying ketamine's antidepressant effects.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Long-Term Impact of Residual Symptoms in Treatment-Resistant Depression
    Fekadu, Abebaw
    Wooderson, Sarah C.
    Rane, Lena J.
    Markopoulou, Kalypso
    Poon, Lucia
    Cleare, Anthony J.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2011, 56 (09): : 549 - 557
  • [22] Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
    Murrough, James W.
    Perez, Andrew M.
    Pillemer, Sarah
    Stern, Jessica
    Parides, Michael K.
    aan het Rot, Marije
    Collins, Katherine A.
    Mathew, Sanjay J.
    Charney, Dennis S.
    Iosifescu, Dan V.
    BIOLOGICAL PSYCHIATRY, 2013, 74 (04) : 250 - 256
  • [23] Inflammation Moderates Antidepressant Response to Ketamine in a Rodent Model of Treatment-Resistant Depression: Bioenergetic and Inflammatory Markers of Response
    Tye, Susannah
    Price, J. Blair
    Walker, Adam
    Kruse, Jennifer
    Cullen, Kathryn
    Frye, Mark
    Schwieler, Lilly
    Erhardt, Sophie
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 277 - 277
  • [24] Inflammation Moderates Antidepressant Response to Ketamine in a Rodent Model of Treatment-Resistant Depression: Bioenergetic and Inflammatory Markers of Response
    Tye, Susannah
    Price, J. Blair
    Walker, Adam
    Kruse, Jennifer
    Cullen, Kathryn
    Frye, Mark
    Schwieler, Lilly
    Erhardt, Sophie
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 277 - 277
  • [25] Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial
    Murrough, James W.
    Burdick, Katherine E.
    Levitch, Cara F.
    Perez, Andrew M.
    Brallier, Jess W.
    Chang, Lee C.
    Foulkes, Alexandra
    Charney, Dennis S.
    Mathew, Sanjay J.
    Iosifescu, Dan V.
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (05) : 1084 - 1090
  • [26] Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial
    James W Murrough
    Katherine E Burdick
    Cara F Levitch
    Andrew M Perez
    Jess W Brallier
    Lee C Chang
    Alexandra Foulkes
    Dennis S Charney
    Sanjay J Mathew
    Dan V Iosifescu
    Neuropsychopharmacology, 2015, 40 : 1084 - 1090
  • [27] Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT
    Allen, A. P.
    Naughton, M.
    Dowling, J.
    Walsh, A.
    Ismail, F.
    Shorten, G.
    Scott, L.
    McLoughlin, D. M.
    Cryan, J. F.
    Dinan, T. G.
    Clarke, G.
    JOURNAL OF AFFECTIVE DISORDERS, 2015, 186 : 306 - 311
  • [28] Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression
    Bekhbat, Mandakh
    Chu, Karen
    Ngoc-Anh Le
    Woolwine, Bobbi J.
    Haroon, Ebrahim
    Miller, Andrew H.
    Felger, Jennifer C.
    PSYCHONEUROENDOCRINOLOGY, 2018, 98 : 222 - 229
  • [29] Exploring Predictors of Ketamine Response in Adolescent Treatment-Resistant Depression
    Lineham, Alice
    Avila-Quintero, Victor J.
    Bloch, Michael H.
    Dwyer, Jennifer
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2024, : 73 - 79
  • [30] Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
    Niciu, Mark J.
    Luckenbaugh, David A.
    Ionescu, Dawn F.
    Guevara, Sara
    Machado-Vieira, Rodrigo
    Richards, Erica M.
    Brutsche, Nancy E.
    Zarate, Carlos A.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 128S - 128S